FTRE - יחס שווי חברה לקצב צמיחת הרווח Fortrea Clinical

Fortrea Holdings Inc. is increasing profits through data automation and a global network of laboratories. On GURU.Markets, the weighted PEG ratio demonstrates the impact of a high dependency on external IT vendors and the current pivot toward debt reduction. The value of 0.44 reflects the latest metric value, helping to determine the extent to which the company's market value aligns with its growth rates.
פילוחי מדדים ואנליטיקה של חברת Fortrea Holdings Inc (FTRE)

The resilience of Fortrea Holdings Inc. (FTRE) depends on the volume of biotech R&D funding and the efficiency of clinical trial management. This indicator correlates the P/E multiple with earnings growth rates, allowing for the identification of an undervalued asset when values fall below one. By analyzing the weighted price-to-earnings-to-growth ratio, an investor identifies the business's margin of safety, filtering out risks associated with operational load and the volatility of client budgets.